Enovis (NYSE: ENOV) has entered into a binding offer to acquire surgical robotics technology developer eCential Robotics for €155 million ($175 million), with up to €35 million ($41 million) in milestone payments, the company announced today.
The transaction is expected to close by the end of 2026, subject to regulatory approvals.
The move would launch the Dallas-based orthopedics company into the surgical robotics technology space, with plans to bring a next-generation surgical robot to market within two years, Enovis CEO Damien McDonald said on an investor call today.
“…We’ll bring the next-generation robot to market within 2 years, first in the knee, where the form factor and product requirements are well understood by the market and eCential already has a validated technology,” he said. “Soon thereafter, we’ll follow in the shoulder.”
McDonald said the merger will enable the company to “bring a differentiated robotic solution to market while also supporting a durable cadence of continuous innovation across enabling technology, robotics, implant design and surgical technique.”
For more on Orthopedics: Download MassDevice’s Orthopedic Device Companies Special Report for 2026
Unlike its competitors in the orthopedics technology space, such as Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet, Enovis has not historically had an in-house robotic orthopedic surgery system.
“With this capability in-house, we’ll have an incredible opportunity to partner with surgeons who want planning, navigation and robotic capabilities,” Enovis CEO Damien McDonald said on an investor call today. “The surgeon who works across a hospital, an outpatient clinic and a couple of ASCs and wants the flexibility to utilize technologies across a connected ecosystem with a single intuitive user experience.”
McDonald said eCential’s technology would also expand Enovis’ current offerings in its Astra profile. Astra provides navigation and planning technology through its Arvis precision guidance headset equipped with augmented reality, and an AI-enabled planning software called Astra Portal.
“The robotic software will integrate seamlessly into the Astra ecosystem, allowing our foundation of AI-enabled planning and navigation to drive both the robot and Arvis,” McDonald said. “Through one integrated workflow, a surgeon does not have to choose between two user experiences.”
McDonald said the current form factor and robotic offerings in shoulder are “suboptimal.” He said “developing a robot with eCential Robotics that carries advantages such as a robotic arm with 7 degrees of Freedom will differentiate our offering in the market,” and mentioned how eCential’s proprietary technology will bring greater precision, flexibility and automation readiness to their design.
“The eCential transaction is more than just a robot, it’s a deliberate strategy to reinforce Enovis’ growth trajectory with a credible long-term position in robotics and advanced enabling tech,” McDonald said.
As part of the agreement, the combined companies will construct a center of excellence for robotics in Grenoble, France.
Associate Editor Skyler Rivera contributed to this report.
